Michael Hay is the Head of Intelligence Products for Informa Pharma and Healthcare. His 16 years of financial markets experience have helped to shape our key products: Citeline, Datamonitor, BioMedTracker and Medtrack.
Michael has consulted for numerous top-tier pharmaceutical companies, and worked closely with top healthcare investment firms to provide insight on investment and trading decisions. He is the co-author of the Nature Biotechnology feature Clinical Development Success Rates for Investigational Drugs.
Michael came to Pharma Intelligence through the acquisition of Sagient in 2012, where he had been since 2004. Previously, he worked as a Manager in Thomson Financial’s Capital Markets Intelligence division.
Michael holds a BSc in Finance from the University of Colorado, Boulder (also his home town).
